Friday, April 3, 2026

Nvidia and Broadcom See Major Gains After Stock Split

Two of the most influential artificial intelligence...

Chinese Foldables Claim to Be Ultra-Thin—Reality Says Otherwise

Chinese smartphone makers mislead on foldable phone thickness; KCEA reveals discrepancies in advertised vs. actual measurements.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

Tag: Phase 1 trials

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.